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Increased lipogenesis is a hallmark of a wide variety of
cancers and is under intense investigation as potential
anti-neoplastic target. Although brisk lipogenesis is
observed in the presence of exogenous lipids, evidence
is mounting that these lipids may adversely affect the
efficacy of inhibitors of lipogenic pathways. Therefore,
to fully exploit the therapeutic potential of lipid synth-
esis inhibitors, a better understanding of the interrela-
tionship between de novo lipid synthesis and exogenous
lipids and their respective role in cancer cell prolifera-
tion and therapeutic response to lipogenesis inhibitors is
of critical importance. Here, we show that the prolifera-
tion of various cancer cell lines (PC3M, HepG2, HOP62
and T24) is attenuated when cultured in lipid-reduced
conditions in a cell line-dependent manner, with PC3M
being the least affected. Interestingly, all cell lines - lipo-
genic (PC3M, HepG2, HOP62) as well as non-lipogenic
(T24) - raised their lipogenic activity in these conditions,
albeit to a different degree. Cells that attained the high-
est lipogenic activity under these conditions were best
able to cope with lipid reduction in term of proliferative
capacity. Supplementation of the medium with very low
density lipoproteins, free fatty acids and cholesterol
reversed this activation, indicating that the mere lack of
lipids is sufficient to activate de novo lipogenesis in can-
cer cells. Consequently, cancer cells grown in lipid-
reduced conditions became more dependent on de novo
lipid synthesis pathways and were more sensitive to
inhibitors of lipogenic pathways, like Soraphen A and
Simvastatin. Collectively, these data indicate that limita-
tion of access to exogenous lipids, as may occur in
intact tumors, activates de novo lipogenesis is cancer
cells, helps them to thrive under these conditions and
makes them more vulnerable to lipogenesis inhibitors.
These observations have important implications for the
design of new anti-neoplastic strategies targeting the
cancer cell’s lipid metabolism.
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